Accepted into StartX Spring 2026, AI-Stroke advances U.S. EMS stroke research with new advisors, clinical studies, and ...
TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...
Hybrid Trial Model Enhances Participant Access, Retention, and Enrollment Efficiency Across Underserved and Rural Communities ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
SAN FRANCISCO, CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Avinasi Labs, an AI-native longevity infrastructure ...
New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Dr Melanie Ivarsson will on Monday be named chief executive of the Health Data Research Service (HDRS), which will give ...
Many positions have remained unfilled for five to 10 years, despite being sanctioned under the Pradhan Mantri Swasthya ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
Objective: To understand patient portal engagement stratified by patient characteristics among adults 50 years and older with at least 1 common chronic medical condition using electronic health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback